Cid S.r.l.

CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010

Older News

WASHINGTON,, September 16, 2010 - CID s.r.l., a European company leader in interventional medicine, will update interventional cardiologists on the status of their revolutionary drug eluting stent technology during The Drug Eluting Stent (DES) Summit at TCT 2010, Washington, DC on Wednesday, September 22, 2010.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy